Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well tipifarnib works in treating older patients with
acute myeloid leukemia. Tipifarnib may stop the growth of cancer cells by blocking some of
the enzymes needed for cell growth.